Research Article
Scientific Evidence of Chinese Herbal Medicine (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis
Table 4
Result of the PRISMA assessments.
| | Section/topic | Items | Tang et al., 2021 | Xing, 2021 | Qin et al., 2019 | Fan, 2019 | Compliance (%) |
| | Title | (Q1) Title | Y | Y | Y | Y | 100% |
| | Abstract | (Q2) Structured summary | Y | Y | Y | Y | 100% |
| | Introduction | (Q3) Rationale | Y | Y | Y | Y | 100% | | (Q4) Objectives | Y | Y | Y | Y | 100% |
| | Methods | (Q5) Protocol and registration | N | N | N | N | 0% | | (Q6) Eligibility criteria | Y | Y | Y | Y | 100% | | (Q7) Information sources | Y | Y | Y | Y | 100% | | (Q8) Search | PY | PY | PY | Y | 25% | | (Q9) Study selection | Y | Y | Y | Y | 100% | | (Q10) Data collection process | Y | Y | Y | Y | 100% | | (Q11) Data items | Y | Y | Y | Y | 100% | | (Q12) Risk of bias in individual studies | Y | Y | Y | Y | 100% | | (Q13) Summary measures | Y | Y | Y | Y | 100% | | (Q14) Synthesis of results | Y | Y | Y | Y | 100% | | (Q15) Risk of bias across studies | Y | Y | Y | Y | 100% | | (Q16) Additional analyses | Y | Y | Y | Y | 100% |
| | Results | (Q17) Study selection | Y | Y | Y | Y | 100% | | (Q18) Study characteristics | Y | Y | Y | Y | 100% | | (Q19) Risk of bias within studies | Y | Y | Y | Y | 100% | | (Q20) Results of individual studies | Y | Y | Y | Y | 100% | | (Q21) Synthesis of results | Y | Y | Y | Y | 100% | | (Q22) Risk of bias across studies | Y | Y | Y | Y | 100% | | (Q23) Additional analysis | Y | Y | Y | Y | 100% |
| | Discussion | (Q24) Summary of evidence | Y | Y | Y | Y | 100% | | (Q25) Limitations | Y | Y | Y | Y | 100% | | (Q26) Conclusions | Y | Y | Y | Y | 100% |
| | Funding | (Q27) Funding | Y | Y | Y | Y | 100% |
|
|
Y: yes; PY: partial yes; N: no.
|
